Terms: = Head and neck cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Treatment
58 results:
1. Imaging as an early biomarker to predict sensitivity to everolimus for progressive nf2-related vestibular schwannoma.
Nghiemphu PL; Vitte J; Dombi E; Nguyen T; Wagle N; Ishiyama A; Sepahdari AR; Cachia D; Widemann BC; Brackmann DE; Doherty JK; Kalamarides M; Giovannini M
J Neurooncol; 2024 Apr; 167(2):339-348. PubMed ID: 38372904
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of autophagy enhances the anticancer effect of schisandrin B on head and neck squamous cell carcinoma.
Li M; Tang Q; Li S; Yang X; Zhang Y; Tang X; Huang P; Yin D
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23585. PubMed ID: 37986106
[TBL] [Abstract] [Full Text] [Related]
3. Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trials.
Staedtke V; Anstett K; Bedwell D; Giovannini M; Keeling K; Kesterson R; Kim Y; Korf B; Leier A; McManus ML; Sarnoff H; Vitte J; Walker JA; Plotkin SR; Wallis D
Clin Trials; 2024 Feb; 21(1):51-66. PubMed ID: 37937606
[TBL] [Abstract] [Full Text] [Related]
4. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
5. Targeted Therapies in the treatment of Vestibular schwannomas: Current State and New Horizons.
Welling DB
Otolaryngol Clin North Am; 2023 Jun; 56(3):543-556. PubMed ID: 37024334
[TBL] [Abstract] [Full Text] [Related]
6. Cellular mechanisms of heterogeneity in nf2-mutant schwannoma.
Chiasson-MacKenzie C; Vitte J; Liu CH; Wright EA; Flynn EA; Stott SL; Giovannini M; McClatchey AI
Nat Commun; 2023 Mar; 14(1):1559. PubMed ID: 36944680
[TBL] [Abstract] [Full Text] [Related]
7. Advances in Targeted Therapy for Neurofibromatosis Type 2 (nf2)-Associated Vestibular schwannomas.
Cumpston EC; Rhodes SD; Yates CW
Curr Oncol Rep; 2023 May; 25(5):531-537. PubMed ID: 36933171
[TBL] [Abstract] [Full Text] [Related]
8. Survival after hemithyroidectomy versus total thyroidectomy in non-high-risk differentiated thyroid cancer: population-based analysis.
Liu X; Wong CKH; Chan WWL; Au ICH; Tang EHM; Lang BHH
BJS Open; 2022 Nov; 6(6):. PubMed ID: 36426588
[TBL] [Abstract] [Full Text] [Related]
9. Approach to the Patient With a Suppressed TSH.
Praw SS; Brent GA
J Clin Endocrinol Metab; 2023 Jan; 108(2):472-482. PubMed ID: 36329632
[TBL] [Abstract] [Full Text] [Related]
10. Reiterative modeling of combined transcriptomic and proteomic features refines and improves the prediction of early recurrence in squamous cell carcinoma of head and neck.
Salehi A; Wang L; Coates PJ; Norberg Spaak L; Gu X; Sgaramella N; Nylander K
Comput Biol Med; 2022 Oct; 149():105991. PubMed ID: 36007290
[TBL] [Abstract] [Full Text] [Related]
11. [Rare tumor of internal auditory canal].
Yang BQ; Yang XL; Wu ZY; Wang L; Ren J; Wang WJ; Hua QQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jul; 57(7):843-847. PubMed ID: 35866277
[No Abstract] [Full Text] [Related]
12. Postpartum Levothyroxine Adjustment and Its Impact Factors in Women With Hypothyroidism in Pregnancy.
Gao X; Liu A; Wang X; Han Y; Wang H; Li J; Hou Y; Yang Y; Wang H; Zhang C; Teng W; Shan Z
Endocr Pract; 2022 Jun; 28(6):578-585. PubMed ID: 35278704
[TBL] [Abstract] [Full Text] [Related]
13. Brigatinib causes tumor shrinkage in both nf2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.
Chang LS; Oblinger JL; Smith AE; Ferrer M; Angus SP; Hawley E; Petrilli AM; Beauchamp RL; Riecken LB; Erdin S; Poi M; Huang J; Bessler WK; Zhang X; Guha R; Thomas C; Burns SS; Gilbert TSK; Jiang L; Li X; Lu Q; Yuan J; He Y; Dixon SAH; Masters A; Jones DR; Yates CW; Haggarty SJ; La Rosa S; Welling DB; Stemmer-Rachamimov AO; Plotkin SR; Gusella JF; Guinney J; Morrison H; Ramesh V; Fernandez-Valle C; Johnson GL; Blakeley JO; Clapp DW;
PLoS One; 2021; 16(7):e0252048. PubMed ID: 34264955
[TBL] [Abstract] [Full Text] [Related]
14. Losartan prevents tumor-induced hearing loss and augments radiation efficacy in nf2 schwannoma rodent models.
Wu L; Vasilijic S; Sun Y; Chen J; Landegger LD; Zhang Y; Zhou W; Ren J; Early S; Yin Z; Ho WW; Zhang N; Gao X; Lee GY; Datta M; Sagers JE; Brown A; Muzikansky A; Stemmer-Rachamimov A; Zhang L; Plotkin SR; Jain RK; Stankovic KM; Xu L
Sci Transl Med; 2021 Jul; 13(602):. PubMed ID: 34261799
[TBL] [Abstract] [Full Text] [Related]
15. Prediction of squamous cell carcinoma cases from squamous cell hyperplasia in throat lesions using CT radiomics model.
Khodrog OA; Cui F; Xu N; Han Q; Liu J; Gong T; Yuan Q
Saudi Med J; 2021 Mar; 42(3):284-292. PubMed ID: 33632907
[TBL] [Abstract] [Full Text] [Related]
16. A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies.
Collier KA; Valencia H; Newton H; Hade EM; Sborov DW; Cavaliere R; Poi M; Phelps MA; Liva SG; Coss CC; Wang J; Khountham S; Monk P; Shapiro CL; Piekarz R; Hofmeister CC; Welling DB; Mortazavi A
Cancer Chemother Pharmacol; 2021 May; 87(5):599-611. PubMed ID: 33492438
[TBL] [Abstract] [Full Text] [Related]
17. Spindle cell hemangioma of nasal passage and ethmoidal sinus in a 4-month old infant.
Tastemel Ozturk T; Suslu AE; Kavuncuoglu A; Gumeler E; Kosemehmetoglu K; Yalcin B
Arch Argent Pediatr; 2021 Feb; 119(1):e36-e40. PubMed ID: 33458988
[TBL] [Abstract] [Full Text] [Related]
18. treatment Analysis and Overall Survival Outcomes of Patients With Bilateral Vestibular schwannoma.
Goshtasbi K; Abouzari M; Yasaka TM; Soltanzadeh-Zarandi S; Sarna B; Lin HW; Djalilian HR
Otol Neurotol; 2021 Apr; 42(4):592-597. PubMed ID: 33351555
[TBL] [Abstract] [Full Text] [Related]
19. The effect of iatrogenic subclinical hyperthyroidism on anxiety, depression and quality of life in differentiated thyroid carcinoma.
Gülsoy Kirnap N; Turhan Iyidir Ö; Bozkuş Y; Işildak ŞM; Anil C; Firat SN; Demir C; Nar A; Başçil Tütüncü N
Turk J Med Sci; 2020 Jun; 50(4):870-876. PubMed ID: 32490648
[TBL] [Abstract] [Full Text] [Related]
20. A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.
Tamura R; Fujioka M; Morimoto Y; Ohara K; Kosugi K; Oishi Y; Sato M; Ueda R; Fujiwara H; Hikichi T; Noji S; Oishi N; Ogawa K; Kawakami Y; Ohira T; Yoshida K; Toda M
Nat Commun; 2019 Dec; 10(1):5758. PubMed ID: 31848332
[TBL] [Abstract] [Full Text] [Related]
[Next]
